International Patent: USE OF COMPLEMENT FACTOR B INHIBITOR IN PREPARATION OF DRUG FOR TREATING OR PREVENTING IGA NEPHROPATHY OR DISEASE OR CONDITION RELATED THERETO

GENEVA, July 2 -- NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/144085) for “USE OF COMPLEMENT FACTOR B INHIBITOR IN PREPARATION OF DRUG FOR TREATING OR PREVENTING IGA NEPHROPATHY OR DISEASE OR CONDITION RELATED THERETO”. With publication no. WO/2026/130552, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/454

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....